DEPLOYDatabase

Robot model

Sentante Endovascular Robotic Platform

surgicalcommercialby Sentante

CE-marked endovascular robotic platform with haptic force feedback for remote vascular interventions.

Track Sentante Endovascular Robotic Platform
Manufacturer
Sentante
Form factor
surgical
Maturity
commercial
Lifecycle
active
Deployments
2
Website
sentante.com ↗

Deploy Watch

Track Sentante Endovascular Robotic Platform on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Track Sentante Endovascular Robotic Platform

Key facts

Intervention scope (company-stated)

Supports peripheral vascular, neurovascular, cardiovascular and electrophysiology procedures using standard guidewires and catheters.

Remote haptic control (company-stated)

A remote workstation and bedside robot, with tactile resistance feedback mirroring the physician's hand movements.

Device capacity (company-stated)

Controls up to three devices at once, including guidewires from .014 to .035 inch.

Catheter range (company-stated)

Catheters from 2Fr to 8Fr on standard off-the-shelf devices, with no proprietary instruments required.

Data & sources

News coverage

1

Web sources

1

2 sources backing this record.View all →

Pricing

No verified price is on record for Sentante Endovascular Robotic Platform. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (2)

Sentante Endovascular Robotic Platform on the deployment map

View the global map

Where Sentante Endovascular Robotic Platform is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Sentante Endovascular Robotic Platform.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://www.medtechdive.com/news/sentante-lands-europes-ce-mark-for-endovascular-robot/820918/
  2. https://sentante.com/product/

Common questions

What is Sentante Endovascular Robotic Platform?
CE-marked endovascular robotic platform with haptic force feedback for remote vascular interventions.
How much does Sentante Endovascular Robotic Platform cost?
Sentante Endovascular Robotic Platform's price is not publicly disclosed. DEPLOY has no verified price on record for Sentante Endovascular Robotic Platform from Sentante. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Sentante Endovascular Robotic Platform actually deployed in the real world?
Yes. Sentante Endovascular Robotic Platform is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Sentante Endovascular Robotic Platform?
Sentante Endovascular Robotic Platform is made by Sentante, based in Vilnius, Lithuania, founded in 2017.
Where is Sentante Endovascular Robotic Platform deployed?
2 verified deployments of Sentante Endovascular Robotic Platform are on the DEPLOY registry, including at United States, Germany, Europe.
Can you buy Sentante Endovascular Robotic Platform?
Sentante Endovascular Robotic Platform is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to Sentante Endovascular Robotic Platform?
On the DEPLOY registry, comparable surgical robots to Sentante Endovascular Robotic Platform include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does Sentante Endovascular Robotic Platform compare to da Vinci (and Ion)?
Sentante Endovascular Robotic Platform and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Sentante Endovascular Robotic Platform has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Sentante Endovascular Robotic Platform a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Sentante Endovascular Robotic Platform ranks in roughly the top 17% of surgical models tracked by the registry.
What is Sentante Endovascular Robotic Platform's maturity stage?
Sentante Endovascular Robotic Platform is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Sentante Endovascular Robotic Platform safe?
Sentante Endovascular Robotic Platform has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-10-10

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-10-10

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
secondary-trade-publication
Trade publication
1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Sentante Endovascular Robotic Platform.